{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:01:25Z","timestamp":1794564085652,"version":"4.9.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-45724-6","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T13:28:36Z","timestamp":1774963716000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluating the correlation between fecal and serum calprotectin in inflammatory bowel disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Luisa","family":"Agnello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina Maria","family":"Gambino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Del Ben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Vassallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cacciabaudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Vastarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Tamburello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Masucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambrogio","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Ciaccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"45724_CR1","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41575-024-01035-7","volume":"22","author":"S Vieujean","year":"2025","unstructured":"Vieujean, S. et al. Understanding the therapeutic toolkit for inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol. 22, 371\u2013394 (2025).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"45724_CR2","doi-asserted-by":"publisher","first-page":"jjaf023","DOI":"10.1093\/ecco-jcc\/jjaf023","volume":"19","author":"A Dal Buono","year":"2025","unstructured":"Dal Buono, A. et al. Assessment of activity and severity of inflammatory bowel disease in cross-sectional imaging techniques: A systematic review. J. Crohns Colitis. 19, jjaf023 (2025).","journal-title":"J. Crohns Colitis"},{"key":"45724_CR3","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3390\/bios15080513","volume":"15","author":"B Teixeira","year":"2025","unstructured":"Teixeira, B., Gon\u00e7alves, H. M. R. & Martins-Lopes, P. Gut feeling: Biomarkers and biosensors\u2019 potential in revolutionizing inflammatory bowel disease (IBD) diagnosis and prognosis\u2014A comprehensive review. Biosensors 15, 513 (2025).","journal-title":"Biosensors"},{"key":"45724_CR4","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.3748\/wjg.v24.i33.3681","volume":"24","author":"MG Mumolo","year":"2018","unstructured":"Mumolo, M. G. et al. From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting. World J. Gastroenterol. 24, 3681\u20133694 (2018).","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"45724_CR5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s12876-025-04035-2","volume":"25","author":"AV Jain","year":"2025","unstructured":"Jain, A. V. et al. Predictive accuracy of fecal calprotectin in assessing clinical activity and disease severity in patients with ulcerative colitis and Crohn\u2019s disease. BMC Gastroenterol. 25 (1), 429 (2025).","journal-title":"BMC Gastroenterol."},{"key":"45724_CR6","doi-asserted-by":"crossref","unstructured":"Wang, W., Cao, W., Zhang, S., Chen, D. & Liu, L. The role of calprotectin in the diagnosis and treatment of inflammatory bowel disease. Int. J. Mol. Sci. 26 (2025). (1996).","DOI":"10.3390\/ijms26051996"},{"key":"45724_CR7","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1038\/ajg.2016.342","volume":"111","author":"R Kalla","year":"2016","unstructured":"Kalla, R., Kennedy, N. A., Ventham, N. T., Boyapati, R. K. & Adams, A. T. Serum calprotectin: A novel diagnostic and prognostic marker in inflammatory bowel diseases. Am. J. Gastroenterol. 111, 1796\u20131805 (2016).","journal-title":"Am. J. Gastroenterol."},{"key":"45724_CR8","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3390\/medicina60050762","volume":"60","author":"A Saviano","year":"2024","unstructured":"Saviano, A. et al. Serum calprotectin in the evaluation of gastrointestinal diseases: An ace up your sleeve? Medicina 60, 762 (2024).","journal-title":"Medicina"},{"key":"45724_CR9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","volume":"13","author":"C Maaser","year":"2019","unstructured":"Maaser, C. et al. ECCO-ESGAR guideline for diagnostic assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. J. Crohns Colitis. 13, 144\u2013164 (2019).","journal-title":"J. Crohns Colitis"},{"key":"45724_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s13631-016-0110-1","volume":"12","author":"M Pradella","year":"2016","unstructured":"Pradella, M. & Cesana, B. M. Linee guida per il confronto di procedure di esami di laboratorio: Utilizzo delle indicazioni di CLSI EP09-A3 ed EP31-A-IR. Riv Ital. Med. Lab. 12, 26\u201335 (2016).","journal-title":"Riv Ital. Med. Lab."},{"key":"45724_CR11","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1053\/j.gastro.2023.09.029","volume":"165","author":"AN Ananthakrishnan","year":"2023","unstructured":"Ananthakrishnan, A. N. et al. AGA clinical practice guideline on the role of biomarkers for the management of Crohn\u2019s disease. Gastroenterology 165, 1367\u20131399 (2023).","journal-title":"Gastroenterology"},{"key":"45724_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/10408363.2019.1619159","volume":"56","author":"A Ricciuto","year":"2019","unstructured":"Ricciuto, A. & Griffiths, A. M. Clinical value of fecal calprotectin. Crit. Rev. Clin. Lab. Sci. 56, 307\u2013320 (2019).","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"45724_CR13","doi-asserted-by":"publisher","first-page":"e0223893","DOI":"10.1371\/journal.pone.0223893","volume":"14","author":"AL Bathe","year":"2019","unstructured":"Bathe, A. L. et al. Impact of faecal calprotectin measurement on clinical decision-making in patients with Crohn\u2019s disease and ulcerative colitis. PloS one. 14, e0223893 (2019).","journal-title":"PloS one"},{"key":"45724_CR14","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1080\/00365521.2018.1527394","volume":"53","author":"R Kalla","year":"2018","unstructured":"Kalla, R. et al. Patients\u2019 perceptions of faecal calprotectin testing in inflammatory bowel disease: Results from a prospective multicentre patient-based survey. Scand. J. Gastroenterol. 53, 1437\u20131442 (2018).","journal-title":"Scand. J. Gastroenterol."},{"key":"45724_CR15","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1177\/2050640616686517","volume":"5","author":"C Mar\u00e9chal","year":"2017","unstructured":"Mar\u00e9chal, C., Aimone-Gastin, I., Baumann, C., Dirrenberger, B. & Gu\u00e9ant, J. L. Peyrin-Biroulet, L. Compliance with the faecal calprotectin test in patients with inflammatory bowel disease. United Eur. Gastroenterol. J. 5, 702\u2013707 (2017).","journal-title":"United Eur. Gastroenterol. J."},{"key":"45724_CR16","first-page":"26","volume":"9","author":"A Lasson","year":"2015","unstructured":"Lasson, A. et al. The intra-individual variability of faecal calprotectin: A prospective study in patients with active ulcerative colitis. J. Crohns Colitis. 9, 26\u201332 (2015).","journal-title":"J. Crohns Colitis"},{"key":"45724_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/MCG.0000000000000776","volume":"52","author":"L Du","year":"2018","unstructured":"Du, L. et al. Within-stool and within-day sample variability of fecal calprotectin in patients with inflammatory bowel disease: A prospective observational study. J. Clin. Gastroenterol. 52, 235\u2013240 (2018).","journal-title":"J. Clin. Gastroenterol."},{"key":"45724_CR18","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1016\/j.cgh.2019.02.017","volume":"17","author":"NA Kennedy","year":"2019","unstructured":"Kennedy, N. A. et al. Association between level of fecal calprotectin and progression of Crohn\u2019s disease. Clin. Gastroenterol. Hepatol. 17, 2269\u20132276e4 (2019).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"45724_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/ibd\/izae032","volume":"31","author":"A Swaminathan","year":"2025","unstructured":"Swaminathan, A. et al. Comparison of fecal calprotectin and myeloperoxidase in predicting outcomes in inflammatory bowel disease. Inflamm. Bowel Dis. 31, 28\u201336 (2025).","journal-title":"Inflamm. Bowel Dis."},{"key":"45724_CR20","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1515\/cclm-2018-0134","volume":"56","author":"A Padoan","year":"2018","unstructured":"Padoan, A. et al. Improving IBD diagnosis and monitoring by understanding preanalytical, analytical and biological fecal calprotectin variability. Clin. Chem. Lab. Med. 56, 1926\u20131935 (2018).","journal-title":"Clin. Chem. Lab. Med."},{"key":"45724_CR21","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/ueg2.12069","volume":"9","author":"F D\u2019Amico","year":"2021","unstructured":"D\u2019Amico, F. et al. International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases. United Eur. Gastroenterol. J. 9, 451\u2013460 (2021).","journal-title":"United Eur. Gastroenterol. J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45724-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45724-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45724-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T22:28:05Z","timestamp":1779056885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45724-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45724"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45724-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15231"}}